Back to Search
Start Over
A Novel and Selective Dopamine Transporter Inhibitor
- Source :
- Biomolecules. 12(7)
- Publication Year :
- 2022
-
Abstract
- Dopamine (DA), the most abundant human brain catecholaminergic neurotransmitter, modulates key behavioral and neurological processes in young and senescent brains, including motricity, sleep, attention, emotion, learning and memory, and social and reward-seeking behaviors. The DA transporter (DAT) regulates transsynaptic DA levels, influencing all these processes. Compounds targeting DAT (e.g., cocaine and amphetamines) were historically used to shape mood and cognition, but these substances typically lead to severe negative side effects (tolerance, abuse, addiction, and dependence). DA/DAT signaling dysfunctions are associated with neuropsychiatric and progressive brain disorders, including Parkinson's and Alzheimer diseases, drug addiction and dementia, resulting in devastating personal and familial concerns and high socioeconomic costs worldwide. The development of low-side-effect, new/selective medicaments with reduced abuse-liability and which ameliorate DA/DAT-related dysfunctions is therefore crucial in the fields of medicine and healthcare. Using the rat as experimental animal model, the present work describes the synthesis and pharmacological profile of (
Details
- ISSN :
- 2218273X
- Volume :
- 12
- Issue :
- 7
- Database :
- OpenAIRE
- Journal :
- Biomolecules
- Accession number :
- edsair.pmid..........79e78bfbbabc89c86a41e19e198b0477